A Novel Mutation of SMAD3 Identified in a Chinese Family with Aneurysms-Osteoarthritis Syndrome

Aneurysms-osteoarthritis syndrome (AOS) is a recently delineated autosomal dominant disorder characterized by aneurysms, dissections, and tortuosity throughout the arterial tree in association with early onset osteoarthritis, mild craniofacial features, and skeletal and cutaneous anomalies. Previous studies have demonstrated that mutations in SMAD3, a key regulator of TGF-β signal transduction, contribute to AOS. Here, we investigated a family of three generations affected by AOS. A novel SMAD3 mutation, c.266G>A (p.C89Y), was identified and cosegregated with the affected individuals in this family. Our finding expands the mutation spectrum of SMAD3 gene and further strengthens the connection between the presence of aneurysms-osteoarthritis phenotype and SMAD3 mutations, which facilitates the understanding of the genotype-phenotype correlation of AOS.

[1]  D. Roden,et al.  Performant Mutation Identification Using Targeted Next‐Generation Sequencing of 14 Thoracic Aortic Aneurysm Genes , 2015, Human mutation.

[2]  B. Starnes,et al.  Endovascular repair of an internal mammary artery aneurysm in a patient with SMAD-3 mutation. , 2015, Journal of Vascular Surgery.

[3]  Chundi Vinay Kumar,et al.  Mutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6 , 2015, Journal of biomolecular structure & dynamics.

[4]  M. Soubrier,et al.  A Case of Rheumatoid Arthritis Associated with SMAD3 Gene Mutation: A New Clinical Entity? , 2015, The Journal of Rheumatology.

[5]  A. De Paepe,et al.  Gene panel sequencing in heritable thoracic aortic disorders and related entities – results of comprehensive testing in a cohort of 264 patients , 2015, Orphanet Journal of Rare Diseases.

[6]  G. Jondeau,et al.  Early-Onset Osteoarthritis, Charcot-Marie-Tooth Like Neuropathy, Autoimmune Features, Multiple Arterial Aneurysms and Dissections: An Unrecognized and Life Threatening Condition , 2014, PloS one.

[7]  Ambuj Kumar,et al.  Use of Long Term Molecular Dynamics Simulation in Predicting Cancer Associated SNPs , 2014, PLoS Comput. Biol..

[8]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[9]  C. Pizarro,et al.  Novel SMAD3 Mutation in a Patient with Hypoplastic Left Heart Syndrome with Significant Aortic Aneurysm , 2014, Case reports in genetics.

[10]  R. Purohit,et al.  Computational SNP Analysis: Current Approaches and Future Prospects , 2013, Cell Biochemistry and Biophysics.

[11]  L. Garavelli,et al.  Thoracic Aortic Aneurysm in Infancy in Aneurysms–Osteoarthritis Syndrome Due to a Novel SMAD3 Mutation: Further Delineation of the Phenotype , 2013, American journal of medical genetics. Part A.

[12]  Rituraj Purohit,et al.  Roadmap to determine the point mutations involved in cardiomyopathy disorder: a Bayesian approach. , 2013, Gene.

[13]  G. Pals,et al.  An unanticipated copy number variant of chromosome 15 disrupting SMAD3 reveals a three‐generation family at serious risk for aortic dissection , 2013, Clinical genetics.

[14]  J. Timmermans,et al.  Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. , 2012, Journal of the American College of Cardiology.

[15]  G. Pals,et al.  Phenotypic spectrum of the SMAD3-related aneurysms–osteoarthritis syndrome , 2011, Journal of Medical Genetics.

[16]  M. Rieder,et al.  Exome Sequencing Identifies SMAD3 Mutations as a Cause of Familial Thoracic Aortic Aneurysm and Dissection With Intracranial and Other Arterial Aneurysms , 2011, Circulation research.

[17]  G. Vriend,et al.  Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis , 2011, Nature Genetics.

[18]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[19]  R. Pyeritz.  Marfan syndrome: 30 years of research equals 30 years of additional life expectancy , 2008, Heart.

[20]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[21]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[22]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[23]  M. Andreassi,et al.  Novel TGFBR2 and known missense SMAD3 mutations: two case reports of thoracic aortic aneurysms. , 2015, The Annals of thoracic surgery.

[24]  M. Andreassi,et al.  Novel TGFBR 2 and Known Missense SMAD 3 Mutations : Two Case Reports of Thoracic Aortic Aneurysms , 2014 .

[25]  I. van Herzeele,et al.  Aneurysm-osteoarthritis syndrome with visceral and iliac artery aneurysms. , 2013, Journal of vascular surgery.

[26]  I. van Herzeele,et al.  Multiple aneurysms in a patient with aneurysms-osteoarthritis syndrome. , 2013, The Annals of thoracic surgery.